Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor-Intolerant Patients

By sjmartinez • January 17, 2023

Schaenman J, Rossetti M, Pickering H, Sunga G, Wilhalme H, Elashoff D, Zhang Q, Hickey M, Reddy U, Danovitch G, Reed EF, Bunnapradist S. Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor-Intolerant Patients. Kidney Int Rep. 2022 Oct 20;8(1):126-140. doi: 10.1016/j.ekir.2022.10.015. PMID: 36644348; PMCID: PMC9832066.

Tags: belatacept, CMV, immunosuppression, Infectious Diseases, Publications, T cell, transplantation

Related Posts

An audit of the HIV drug resistance testing program in Malawi

Kanise H, Nyirenda K, Bisani P, Matola BW, Makwaya A, Simon K, Cox C, Hosseinipour MC, Kanyama C, Worku A, Phiri S, Hoffman RM, Nyirenda[...]

Blood pressure trajectories among people with and without HIV in a US-based prospective cohort study

Sadinski LM, Edwards JK, Herce ME, Avery CL, Miller WC, Simpson RJ Jr, Ramirez C, Palella FJ, Brown TT, Detels R, Magnani JW, Levitan EB,[...]

A taxon-specific measurement of disruption in a multi-modal study of microbiomes and metabolomes reveals system-wide dysbiosis preceding HIV-1 infection

Fouladi F, Chen Y, Bera S, Jarmusch AK, Van Tyne D, Palella FJ, Margolick JB, Chew KW, Sun J, Martinson J, Rinaldo CR, Peddada SD.[...]